These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6527140)

  • 1. The sensitivity of hippocampal pyramidal neurons to serotonin in vitro: effect of prolonged treatment with clorgyline or clomipramine.
    Olpe HR; Schellenberg A; Jones RS
    J Neural Transm; 1984; 60(3-4):265-71. PubMed ID: 6527140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of clomipramine and clorgyline on the sensitivity of cortical neurons to serotonin: effect of chronic treatment.
    Olpe HR
    Eur J Pharmacol; 1981 Jan; 69(3):375-7. PubMed ID: 7215435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of cortical neurons to serotonin: effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs.
    Olpe HR; Schellenberg A
    J Neural Transm; 1981; 51(3-4):233-44. PubMed ID: 6793695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological and receptor studies in rat brain: effects of clorgyline.
    Campbell IC; Gallager DW; Hamburg MA; Tallman JF; Murphy DL
    Eur J Pharmacol; 1985 May; 111(3):355-64. PubMed ID: 2990957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin depression of local cerebral glucose utilisation after monoamine oxidase inhibition.
    Grome JJ; Harper AM
    J Cereb Blood Flow Metab; 1985 Sep; 5(3):473-5. PubMed ID: 4030926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats.
    Mousseau DD; Greenshaw AJ
    J Neural Transm; 1989; 75(1):73-9. PubMed ID: 2465373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition by clorgyline of 5-hydroxytryptamine deamination by the rat liver.
    Fowler CJ; Callingham BA
    J Pharm Pharmacol; 1978 May; 30(5):304-9. PubMed ID: 26745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of electrophysiology to the study of tianeptine and other antidepressive agents].
    Dresse A; Scuvée-Moreau J; Mocaaër E; Poignant JC
    Presse Med; 1991 Nov; 20(37):1807-11. PubMed ID: 1836612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.
    Newman ME; Gur E; Dremencov E; Garcia F; Lerer B; Van de Kar LD
    Neuropharmacology; 2000 Sep; 39(12):2309-17. PubMed ID: 10974314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
    Hulihan-Giblin BA; Park YD; Aulakh CS
    Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment.
    Cohen RM; Aulakh CS; Campbell IC; Murphy DL
    Eur J Pharmacol; 1982 Jun; 81(1):145-8. PubMed ID: 6288399
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine.
    Cohen RM; Aulakh CS; Murphy DL
    Eur J Pharmacol; 1983 Oct; 94(1-2):175-9. PubMed ID: 6653658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
    Chenu F; El Mansari M; Blier P
    Int J Neuropsychopharmacol; 2009 May; 12(4):475-85. PubMed ID: 18700056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidation in subfractions of crude mitochondria of rat brain by clorgyline and Lilly 51641.
    Mitra C; Guha SR
    Biochem Pharmacol; 1978; 27(20):2455-7. PubMed ID: 728196
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
    Graham D; Tahraoui L; Langer SZ
    Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic treatment with clorgyline on the relative concentration of specific proteins in the hippocampus and parietal cortex of the rat.
    Sills MA; Heydorn WE; Cohen RM; Creed GJ; Jacobowitz DM
    Neuropharmacology; 1986 Feb; 25(2):143-50. PubMed ID: 3703169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.
    Aulakh CS; Hill JL; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1988; 95(3):313-7. PubMed ID: 3137616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
    Mishra R; Sulser F
    Commun Psychopharmacol; 1978; 2(4):365-9. PubMed ID: 310378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.